
    
      Twenty four patients with IBS-D or IBS-M according to the ROME III criteria, will be enrolled
      in the study.

      Having meet inclusion criteria, the patients are randomised to receive either OFF-subsensory
      or subsensory-OFF stimulation in a 2+2-week period followed by 2 weeks of suprasensory
      stimulation. Hereby rendering a percutaneous nerve evaluation (PNE) test of a total of 6
      weeks.

      During the PNE test the effect of the stimulation is evaluated by specific IBS symptom and
      quality of life questionnaires (GSRS-IBS and IBS-IS) and bowel habit diaries.
    
  